Next Dnex?

good results coming?

If there is any chance of Govt-Private effort where vaccines are concerned, this group is in good hands as they are already well spread out throughout the major cities and ready in terms of facilities.

No incentive to move, dont waste your sleep trying to hope for this - move to other counters that have not moved yet. Tech counter coming back to life.

@super_newbie Straits associate firm Banle Energy to file for HK IPO
https://www.thestar.com.my/business/business-news/2021/03/02/straits-a...


News came out in afternoon, just before sell-down. Go figure why investors pulled out at the last minute. There is no material gain from this - at least not in another financial year AFTER listing at the Hang Seng.

Immediate target 0.35 if it breaks 0.30 today. Read up on the company - look into previous stock buy-ups and look deep. You will have an idea why this sudden movement,

Yesterday's market volume only by Singapore entity. Wa bought by local retailers. If you look at conversion, might as well buy the mother share.

If XOX Buys into cheetah and cheetah price goes up, you know very well how much the holding company is worth. No need to beat round the bush hoping for people to panic and sell cheap - newbies might, but seasoned traders watching will only laugh.

@Sunshine123 This stock is a buy till 4.50-4.60 for its true value. Looking at past quarters, you must admit that the management is holding pretty well against NPLs and other short-term liabilities. If the OPR rates are not lowered by Bank Negara, you can expect a higher price for this. In an opening economy, only good financial sectors will charge fullsteam ahead. Look at Buffett's past 30 years investing trends. There you will find some answers to what will happen six months down the Malaysian market as the people are innoculated. Good luck.

https://www.nst.com.my/business/2020/06/604451/vsolar-global-re-investors-radar

5sen coming

Despite good deals signed it is still dropping like a durian.

Cup and handle forming this week

inverted cross - be careful. investors dont see a direction, selling pressure may come as they take profit

https://www.malaymail.com/news/malaysia/2021/02/19/putrajaya-cloud-service-providers-to-invest-up-to-rm15b-under-the-digital-e/1951011

Profit-taking this morning.. wont trust this until late afternoon. May drop below 0.30 again unless something substantial is announced.

Pfizer vaccine coming in already. could it be Bintai's cold-trans facility getting jobs?

Looks like Bintai's GNBT vaccine might be useful after all

Sold 0.305!

0.32 is the target today if it hits its 68.8 fabionacci level of 0.29.

8c could be the new normal. hang on tight

Wait till vaccine deployment - then you will see this 7-11 of hospitals wake up in terms of profits. Right now, it's a steal at this price.

Generex Biotechnology is moving north sharply. Pay attention. That is Bintai's principal.

PM announcing vaccination plan now. Can hope for glove and medical facilities counters to move from this point.

Kanger probably not going anywhere with its vaccine venture - bamboo will also take some time to develop to full potential. So, buy, keep, go to sleep and set alerts on. Once your first TP is reached, sell.

hate to share this but someone here is right - you can clearly see that Kanger is not in the play where vaccines are concerned. The sad thing is the company has not come up with any explanation - it goes to show there is no good corporate governance and investor reporting.


https://www.salaamgateway.com/story/parallel-covid-19-vaccines-will-be-available-in-malaysia-to-counter-halal-uncertainty

Looks like the wait is not fruitless

MALAYSIA’S VACCINE OPTIONS

Malaysia’s roll-out will begin with the first of 12.7 million doses already ordered from Pfizer-BioNtech.
This will be followed by 14 million Sinovac doses, as well as 6.4 million doses from the World Health Organisation's COVAX facility and another 6.4 million from AstraZeneca/Oxford. The last one is the only government-ordered vaccine that does not use mRNA, and is single-dose.
Generex and China’s Anhui Zhifei Longcom Biopharmaceutical have both signed distribution agreements for their parallel vaccines with Malaysian companies Bintai Kinden and MYEG, respectively. The Anhui Zhifei drug also expects to obtain halal certification. Both are currently in late-stage trials.

https://www.salaamgateway.com/story/parallel-covid-19-vaccines-will-be-available-in-malaysia-to-counter-halal-uncertainty

This company is effed good. Looking at the performance, the entire board should go. How can the price dip so much when demand is consistent?

Dont hope too much for its involvement in Malaysia. So far, only Pharmaniaga awaiting approval for local roll-out. If Kanger is responsible, it would have said something already. As if its corporate people didnt understand the word investor relations.

Mixed development with healthcare project it has undertaken appears to be a senior living ommunity, a relatively new living concept in Malaysia with good prospects. It has happened in Australia with increased ageing population, and Japan as well as Taiwan. It will be a good thing in Malaysia considering the country marching towards high-end society and an ageing population that can spend money.

@tc8787

Something big could be in the works if you analyse the CEO's statement.

Also monitor GNBT stocks - heavy buyup yesterday. Now hitting 0.43 USD. Maybe it is finally reaching the end of its vaccine venture and ready to show the product. Funds are moving in, as well as smart money. If its li-Key peptide based vaccine is successful, then it will be a gamechanger for current models. Check its fund profiles and you will know what is coming for its associates worldwide (including Bintai Kinden).

gone - this counter is totally finished. next step, share consolidation.

Heard Pfizer has arrived. Cold transport is being sought. Let's hope Bintai will be one of the beneficiaries.

No way this stock will fly like last year. There simply are no incentives and with the MCO, production will be affected

Thanks, I will throw and run very far.

Gone with the wind. Final data or not, the drop is real.

Look at the candle. Gap up? Let's see where it finishes. Macd is weakening. Not surprised if it drops back to 0.70

Looks like it is game over - or 15 sen coming again?

LKL is not only involved in beddings for hospitals. With KKM's estimate of 5,000 cases a day next month, quarantine at home may not be viable - and I think they are also looking at hotels and other premises for help, including private hospitals. If my guess is right, private hospitals that treat covid patients will refurbish their beds once the pandemic is over because of the stigma. but let's watch and see what happens. By the way, what about LKL's glove venture to China. Any news from there yet?

@
paulthesotong Final " data" n testing coming out end of this mth or early Feb..." Suprising" " Home Run"
20/01/2021 7:22 AM

What data? That it is ready for Phase 3 or FDA approves? If so, you are not looking at 80sen but maybe $8, but heck, just wait

Flash in the pan - already people start selling down. hard times, looking for fast buck. be careful.

Good beginnings

https://www.thestar.com.my/business/business-news/2021/01/18/quick-take-kanger-gains-3-on-diversification-into-construction

Monitor Generex stock on the US exchange under OTC. markets. That will be your signal

Sinopharm was approved by China on dec 31. Malaysia will do phase trials on Jan 21

GNBT hit a high of USD45 yesterday before retracing. Something is developing fast at Generex Biotech - it must be its li-peptide based vaccine. That it has attracted substantial funds is no surprise and by association, Bintai Kinden now has something - apart from the distribution of the Korean cold-trans box for vaccines - to bank on. Let's watch the take-up today. The charts look good - MA 5/20 looks promising

Pfizer vaccine needs cold trans. One other company ready to tap into this is AHealth. Now that BK is also on the bandwagon, you can bet the playing rules has just gotten interesting. Vaccine considered as well, BK must first break 0.79 resistance to head for greater days reflected by its fundamentals. Next resistance if 0.79 is broken will be 0.96

GNBT is is the rise - meaning their research into li-peptide based vaccines are drawing interest. This is the stock that one should monitor. It is today 0.40 - a far cry from its 0.19 price some months back. What is interesting is if you look at its technicals, it is on the climb - especially markedly yesterday. Anticipate some announcement of sorts to come soon. And if it does, then you will see some interesting fireworks in BK by sheer association

This is just a measure to prevent a general election - a political emergency so that politicians are tied down.

PM said phase 3 volunteer testing of the China vaccine will begin in nine days time. It will involved 3,000. Now the question to as is if Kanger is still the distributor for this China vaccine (Singopharm's Verocell). If it is, then you may draw your own conclusions.

The speech:

"37. Kajian klinikal yang pertama dilakukan di Malaysia ini dijangka akan melibatkan seramai 3,000 sukarelawan dan Malaysia bakal menjadi negara pertama di luar negara China untuk kajian calon vaksin inactivated COVID-19 vaccine buatan Institute of Medical Biology Chinese Academy of Medical Sciences, China (IMBCAMS) ini. Kesemua keperluan regulatori termasuk kelulusan etika dari Medical Review & Ethics Committee (MREC) dan akhir sekali, Clinical Trial Import License (CTIL) dari NPRA telah diperolehi pada 8 Januari 2021."